Covered recipient · General Payments record
DAYNA NICOLE STATES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,470.62
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $477.98 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $164.27 | 10 |
| Exact Sciences Corporation | $96.68 | 4 |
| Novo Nordisk AS | $65.31 | 4 |
| Astellas Pharma US Inc | $60.24 | 3 |
| Lilly USA, LLC | $37.93 | 2 |
| Otsuka America Pharmaceutical, Inc. | $20.59 | 1 |
| Lundbeck LLC | $17.83 | 1 |
| PFIZER INC. | $15.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.27 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246972 | CMS |
| ABBVIE INC. | $19.27 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246974 | CMS |
| ABBVIE INC. | $18.08 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246976 | CMS |
| ABBVIE INC. | $13.45 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246978 | CMS |
| ABBVIE INC. | $13.69 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246980 | CMS |
| ABBVIE INC. | $17.72 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246982 | CMS |
| ABBVIE INC. | $18.88 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246984 | CMS |
| ABBVIE INC. | $19.76 | 11/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246986 | CMS |
| ABBVIE INC. | $11.58 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246988 | CMS |
| ABBVIE INC. | $14.57 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108246990 | CMS |
| Astellas Pharma US Inc | $13.65 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139516239 | CMS |
| Astellas Pharma US Inc | $14.48 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139544609 | CMS |
| Astellas Pharma US Inc | $32.11 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139551117 | CMS |
| Exact Sciences Corporation | $20.76 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114538775 | CMS |
| Exact Sciences Corporation | $26.24 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114538779 | CMS |
| Exact Sciences Corporation | $26.34 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114538783 | CMS |
| Exact Sciences Corporation | $23.34 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114538787 | CMS |
| Lilly USA, LLC | $16.99 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135612870 | CMS |
| Lilly USA, LLC | $20.94 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135605331 | CMS |
| Lundbeck LLC | $17.83 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146093808 | CMS |
| Novo Nordisk Inc | $13.69 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100610114 | CMS |
| Novo Nordisk Inc | $18.05 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100352178 | CMS |
| Novo Nordisk Inc | $16.38 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100284816 | CMS |
| Novo Nordisk Inc | $17.19 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100563053 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.59 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119192182 | CMS |
| PFIZER INC. | $15.13 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131995879 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.